Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Insulin Resistance × Pioglitazone × Clear all

Phase

Phase 4 3 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Insulin Resistance 1 Inflammation 1 Hyperinsulinism 1 Breast Neoplasms 1

Interventions

Tirzepatide 1 Tablets 1 Pioglitazone 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

St. Louis University

Phase EARLY_PHASE1 Withdrawn

Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡